Adam Wahida

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Stem Cell Transplantation

Transcranial Magnetic Stimulation

Childhood Cancer

Top Venues

Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V

Nature reviews. Cancer

Proceedings of the National Academy of Sciences of the United States of America

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed A Gouda, Lars Buschhorn, Andreas Schneeweiß, Adam Wahida, Vivek Subbiah
N-of-1 Trials in Cancer Drug Development. Cancer discovery (2023)
Adam Wahida, Lars Buschhorn
Liquid biopsies and those three little words: finding the perfect match for the MTB. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V 35 (4) (2023)
Mohamed A Gouda, Blessie Elizabeth Nelson, Lars Buschhorn, Adam Wahida, Vivek Subbiah
Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical implications. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Adam Wahida, Lars Buschhorn
Liquid biopsies and those three little words: finding the perfect match for the MTB. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V 35 (4) (2023)
Adam Wahida, Lars Buschhorn, Stefan Fröhling, Philipp J Jost, Andreas Schneeweiss, Peter Lichter, Razelle Kurzrock
The coming decade in precision oncology: six riddles. Nature reviews. Cancer (2022)
Kathrin Kobus, Bianca Bohmann, Manuel Wilbring, Marvin Kapalla, Hans-Henning Eckstein, Florian Bassermann, Jan A Stratmann, Adam Wahida, Christian Reeps, Benedikt J Schwaiger, Albert Busch, Aaron Becker von Rose
Cancer, cancer treatment and aneurysmatic ascending aorta growth within a retrospective single center study. VASA. Zeitschrift fur Gefasskrankheiten (2022)
Farzaneh Ghazavi, Jelle Huysentruyt, Jordy De Coninck, Stephanie Kourula, Sofie Martens, Behrouz Hassannia, Tim Wartewig, Tatyana Divert, Ria Roelandt, Bastian Popper, Andreas Hiergeist, Peter Tougaard, Tom Vanden Berghe, Marie Joossens, Geert Berx, Nozomi Takahashi, Adam Wahida, Peter Vandenabeele
Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state. Proceedings of the National Academy of Sciences of the United States of America 119 (6) (2022)
Adam Wahida, Madeleine Müller, Andreas Hiergeist, Bastian Popper, Katja Steiger, Caterina Branca, Markus Tschurtschenthaler, Thomas Engleitner, Sainitin Donakonda, Jordy De Coninck, Rupert Öllinger, Marie K Pfautsch, Nicole Müller, Miguel G Silva, Sinem Usluer, Erik Thiele Orberg, Jan P Böttcher, Nicole Pfarr, Martina Anton, Julia B Slotta-Huspenina, Andreas G Nerlich, Tobias Madl, Marijana Basic, Marijana Basic, Geert Berx, Juergen Ruland, Percy A Knolle, Roland Rad, Timon E Adolph, Peter Vandenabeele, Hirokazu Kanegane, André Gessner, Philipp J Jost, Monica Yabal
XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells. Science immunology 6 (65) (2021)
Judith S Hecker, Adam Wahida, Erik Hameister, Aneta Filo, Jürgen Ruland, Florian Bassermann, Martin Hildebrandt, Mareike Verbeek, Hendrik Poeck
ABO subgroup incompatibility with severe hemolysis after consecutive allogeneic stem cell transplantations. EJHaem 2 (2) (2021)
Enkhtsetseg Munkhbaatar, Michelle Dietzen, Deepti Agrawal, Martina Anton, Moritz Jesinghaus, Melanie Boxberg, Nicole Pfarr, Pidassa Bidola, Sebastian Uhrig, Ulrike Höckendorf, Anna-Lena Meinhardt, Adam Wahida, Irina Heid, Rickmer F Braren, Ritu Mishra, Arne Warth, Thomas Muley, Patrina S P Poh, Xin Wang, Stefan Fröhling, Katja Steiger, Julia Slotta-Huspenina, Martijn van Griensven, Franz Pfeiffer, Sebastian Lange, Roland Rad, Magda Spella, Georgios T Stathopoulos, Juergen Ruland, Florian Bassermann, Wilko Weichert, Andreas Strasser, Caterina Branca, Mathias F Heikenwälder, Charles Swanton, Nicholas McGranahan, Philipp J Jost
MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically. Nature communications 11 (1) (2020)